Subscribe: Market Wire - Medical and Healthcare: Surgery and Treatments
http://img.marketwire.com/rss/mwMHSU.rss
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
cannabis  company  feb  health  healthcare  marketwired feb  marketwired february  marketwired  new  otcqb  sanuwave  technology 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Surgery and Treatments

Marketwired - Surgery and Treatments



Marketwired - Surgery and Treatments



Last Build Date: Mon, 27 Feb 2017 10:53:02 EST

Copyright: Copyright: (C) Marketwired
 



Medovex Files Form 8K Affirmatively Stating Current Compliance with NASDAQ's Stockholders Equity Requirement

Mon, 27 Feb 2017 10:43:50 EST

ATLANTA, GA--(Marketwired - Feb 27, 2017) -  Medovex Corp. (NASDAQ: MDVX), a developer of medical technology products, today announced that on Friday, February 24, 2017, the Company filed a Form 8K with the Securities and Exchange Commission affirmatively stating its current compliance with NASDAQ's stockholder equity requirement.




Dr. Lisa A. Fortier Joins TissueGen's Scientific Advisory Board

Mon, 27 Feb 2017 10:00:00 EST

Expert in Application of Biologics for Cartilage Repair and Tendinosis Joins Team Pioneering Advances in Drug Delivery, Nerve Regeneration and Tissue Engineering




Lice Clinics of America Opens New Treatment Center in Vernon Hills

Mon, 27 Feb 2017 09:49:21 EST

Clinic provides guaranteed, one-and-done lice treatments using FDA-cleared medical device




Health Advance Inc. Announces $7 Million Financing Agreement with GHS Investments

Mon, 27 Feb 2017 09:47:49 EST

LAS VEGAS, NV--(Marketwired - Feb 27, 2017) -  Health Advance Inc. (the "Company" or "Health Advance") (OTC PINK: HADV) is pleased to announce that the Company has entered into an Equity Financing Agreement ("Agreement") with GHS Investments LLC, a Nevada limited liability company (Hereinafter referred to as "GHS"). The Agreement allows Health Advance to access up to $7 million in capital over the next 24 months. This financing will also allow the Company to continue its growth through acquisitions and will allow the Company to effectively execute its business plan and growth model.




Advantis Corp. Striking Agreement to Triple Amstercan Packaging Efficiency

Mon, 27 Feb 2017 09:28:00 EST

NEWPORT BEACH, CA--(Marketwired - Feb 27, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) is currently negotiating with N2Pack in order to get a more efficient Amstercan packaging machine. N2Pack is the manufacturer that currently supplies canning equipment for Advantis.




Ritter Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Business Update

Mon, 27 Feb 2017 09:00:00 EST

LOS ANGELES, CA--(Marketwired - Feb 27, 2017) - Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) ("Ritter Pharmaceuticals" or the "Company"), a leading developer of novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases, today reported financial results for the fourth quarter and full year ended December 31, 2016.




BriaCell CEO Equity Investment Advances Company's Lead Cancer Product and Pipeline Expansion

Mon, 27 Feb 2017 08:30:00 EST

BERKELEY, CA and VANCOUVER, BC --(Marketwired - February 27, 2017) - BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX VENTURE: BCT) (OTCQB: BCTXF) announced today that its President and CEO, Dr. William Williams has entered into a non-brokered private placement (the "Offering") of 5,416,667 units of the Company (the "Units") at a price of C$0.24 per Unit for aggregate gross proceeds of C$1,300,000. Under the terms of the Offering, each Unit shall consist of one common share in the capital of the Company (a "Common Share") and one-half of a Common Share purchase warrant (a "Warrant"). Each Warrant will be exercisable for one Common Share at an exercise price of C$0.35. The Warrants will be exercisable for 24 months following the date of closing of the Offering. The Offering is subject to the approval of the TSX Venture Exchange and other customary closing conditions.




Arch Therapeutics to Provide Corporate Update at the Maxim Group - Haitong Securities Healthcare Investor and Partnering Conference

Mon, 27 Feb 2017 08:18:29 EST

FRAMINGHAM, MA--(Marketwired - Feb 27, 2017) -  Terrence Norchi, MD, CEO of Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will present at the Maxim Group - Haitong Securities Healthcare Investor and Partnering Conference taking place from March 6-7, 2017 at the Park Hyatt Shanghai in Shanghai, China.




Velano Vascular Receives Third FDA 510(k) Clearance for Innovative PIVO Needle-Free Blood Draw Technology

Mon, 27 Feb 2017 08:00:00 EST

Next generation design enables hospitals to deliver more compassionate, standardized, patient-centered blood draws




Dr. Timothy Greco Now Offers Volbella(R) in Philadelphia

Sat, 25 Feb 2017 09:00:00 EST

By adding Juvederm Volbella(R) to his Philadelphia-area practice, Dr. Timothy Greco kicked off 2017 with more options than ever for patients looking for nonsurgical cosmetic options for the face




Cannabis Science Announces Update on Proposed DPI Inhalation Device, CBD Infused Pain Patch, and Extends Praise for President Trump's Support of Medical Cannabis, Nationwide

Fri, 24 Feb 2017 11:06:27 EST

IRVINE, CA--(Marketwired - Feb 24, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce updates on the proposed self-medicating DPI Inhalation Device for Asthma/COPD and our Cannabinoid infused pain patch. The Company is working on the final packaging for the Cannabinoid-based Pain Patches and will roll out to partner dispensaries in the Los Angeles area very soon, joining the existing Cannabis Science product line.




Medifirst Solutions Updates Shareholders

Fri, 24 Feb 2017 11:00:00 EST

FREEHOLD, NJ--(Marketwired - Feb 24, 2017) -  MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) (the "Company" or "Medifirst") would like to update shareholders in order to follow up on its Time Machine Conference in Morocco, as well as to provide recent Company developments regarding its FDA cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device.




ALGAE DYNAMICS CORP Announces Research Agreement With University of Waterloo to Investigate Use of Cannabis Oil in the Context of Cancer

Fri, 24 Feb 2017 09:30:00 EST

TORONTO, ON--(Marketwired - Feb 24, 2017) - ALGAE DYNAMICS CORP (OTCQB: ADYNF) (the "Company"), a development stage company focused on the commercialization of its proprietary BioSilo® cultivation and extraction system for the growth of algae strains for use in the food and health supplement industry, today announced a research agreement with the University of Waterloo to perform fundamental research on cannabis oil and its constituents in the context of the development and treatment of cancers of the colorectum, pancreas, breast and prostate. The Sponsored Research Agreement is entitled "Studies on botanical oils from Algae Dynamics".




SANUWAVE Receives U.S. Patent for a Special Construction of Shock Wave Electrodes and the Method to Adjust Their Spark Gap

Fri, 24 Feb 2017 09:00:00 EST

SUWANEE, GA--(Marketwired - Feb 24, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) today announced that the U.S. Patent and Trademark Office (USPTO) has issued the Company patent number 9,566,209 titled "Shock Wave Electrodes with Fluid Holes" that has an expiration date on June 21, 2033. This patent relates to a new construction of the spark gap electrodes used to generate acoustic pressure shock waves in SANUWAVE's devices, which allows a longer useful life for the applicators. The twenty (20) claims of the patent cover the construction of the acoustic pressure shock wave applicators that incorporate such electrodes and methods to adjust the spark gap distance in between the electrodes using calculation of equivalent capacitance of the applicator's head.




CloudHealth Genomics Presents their Unique Market Strategy and ImmuneSeq(TM) Panel for both Cancer and Non-Cancer Immunotherapies

Thu, 23 Feb 2017 14:06:03 EST

BOSTON, MA and SHANGHAI, CHINA--(Marketwired - Feb 23, 2017) - CloudHealth Genomics, Ltd., a leading genomics-based precision medicine solutions provider in China, presented data today on their unique business model, using open and disruptive innovation as a market strategy for precision medicine, wellness and longevity. In addition, data was presented as a by-product of the model, ImmuneSeq panel at the Cambridge Healthtech Institute's Third Annual Commercialization of Molecular Diagnostics, part of the 24th International Molecular Medicine Tri-Conference held in San Francisco, CA. ImmuneSeq is able to monitor immune responses, like T-cell activities for both cancer and non-cancer immunotherapies.




Olive Fertility Centre Voted Best Fertility Clinic in Vancouver

Thu, 23 Feb 2017 13:45:02 EST

VANCOUVER, BC--(Marketwired - February 23, 2017) - Olive Fertility Centre is proud to announce that they have won Gold for Best Fertility Clinic in Vancouver in the West Ender's 20th Annual Best of the City reader's Poll.




Vancouver Aesthetic Doctor Offers Spring Skincare Tips

Thu, 23 Feb 2017 13:41:41 EST

Vancouver aesthetic doctor advises changing skincare routine in spring to help stay fresh-faced




iData Research Publishes Article on U.S. Orthopedic Biomaterials Market: Shift in Competitive Strategy

Thu, 23 Feb 2017 13:20:51 EST

Cellular allografts currently comprise the fastest growing segment of the orthopedic biomaterials market in the U.S.; the high average selling price of cellular allografts provides incentives for new players to enter the market




Somnia Announces Winner of Sixth Annual CRNA of the Year Award

Thu, 23 Feb 2017 10:00:00 EST

Randy Graybeal of Washington State-based PRMC Selected




Agritek Holdings, Inc. Announces Plans For Additional Cultivation Property With Licenses In Colorado On Heels of Receiving Listing In First Proposed Cannabis Exchange Fund (ETF)

Thu, 23 Feb 2017 09:19:42 EST

LOS ANGELES, CA--(Marketwired - Feb 23, 2017) - Agritek Holdings, Inc. (OTC PINK: AGTK), a leader in compassionate care technology and agricultural solutions for the recreational cannabis industry, today announced that the Company has entered into negotiations to purchase an additional thirty-five (35) acre property located in Pueblo county which has already been approved and received licenses for cultivation. The new property with existing structures will be managed on behalf of Agritek by licensed cultivators with a strong track record within the state. Additional plans for a manufacturing facility and recreational license to work in cooperation with the recently announced and completed purchase of the eighty (80) acre parcel and proposed cannabis farm for the medicinal and recreational sector located in Pueblo, Colorado will also be under the same operational agreement.




First Ever Cannabis-Based ETF to Include PharmaCyte Biotech, Abbott Laboratories, and GW Pharmaceuticals

Thu, 23 Feb 2017 09:15:00 EST

NEW YORK, NY--(Marketwired - February 23, 2017) - PharmaCyte Biotech (OTCQB: PMCB) will join GW Pharmaceuticals, Abbott Laboratories and 66 other publicly traded companies in what could be the first ever cannabis exchange-traded fund (ETF) -- the Emerging AgroSphere ETF. One week ago, ETF Managers Group, headquartered in Summit, New Jersey, filed an initial registration statement with the SEC to become the first of its kind in the ETF industry (https://www.sec.gov/Archives/edgar/data/1467831/000114420417009539/v459698_485apos.htm).




Early Birds May Make Healthier Food Choices Than Night Owls

Thu, 23 Feb 2017 09:00:00 EST

New Study First to Link Internal Clock to What and When People Eat




SANUWAVE Health, Inc. Launches "SHOCK THIS" Blog

Thu, 23 Feb 2017 09:00:00 EST

SUWANEE, GA--(Marketwired - Feb 23, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) announces the launch of the blog, SHOCK THIS on its website www.sanuwave.com. The initial post will be from SANUWAVE's head of Research and Development, Dr. Iulian Cioanta, titled "What is a shockwave." The goal of the blog is to allow a medium to help educate customers, patients, partners, and the public about the various initiatives under way at SANUWAVE. The blog will also accept posts and comments (approved by SANUWAVE), which the Company views as valuable to the SANUWAVE community. This is expected to be a constructive forum for users from around the globe. By having a central location, SHOCK THIS, the Company can bring together in one setting various information that will be useful and entertaining to the SANUWAVE community. The initial blog is meant to help people understand, what is a shock wave. Many misconceptions exist about the technology, what it is and what it isn't, so the plan is to help expand people's understanding by educating in a fun manner. Members of the SANUWAVE community are encouraged to interact and reach out with thoughts and ideas, which will positively impact the SANUWAVE community as a whole. SANUWAVE Health, Inc. reserves the right to edit or exclude comments it deems not positively impacting the experience or is not appropriate from legal and regulatory perspectives. Kevin Richardson, SANUWAVE's Acting CEO, said, "This is an exciting launch for us as SANUWAVE begins the process of educating the market on the Company's technology and devices' capabilities. In the hopes of receiving FDA approval in the future, this is a first step in building SANUWAVE brand awareness."




New Jersey Plastic Surgeons Introduce Non-Surgical Facelift Alternative

Thu, 23 Feb 2017 07:01:00 EST

Luis A. Zapiach, MD and John T. Cozzone, MD now offer the Silhouette InstaLift for non-surgical facelifting at their New York Metro area plastic surgery practice




The Waldorf Center Introduces ThermiVa(R) to Portland

Wed, 22 Feb 2017 16:30:00 EST

Vaginal rejuvenation is the latest addition to the menu of services at The Waldorf Center for Plastic Surgery, now offering the nonsurgical ThermiVa(R). Portland-area patients can experience its benefits as of late 2016 and early 2017




UPDATE - 2016 Toronto Consumer Choice Award Winners

Wed, 22 Feb 2017 16:20:48 EST

TORONTO, ON--(Marketwired - February 22, 2017) - Consumer Choice Award is pleased to present the 2016 Top Service Providers for the Greater Toronto Area in their respective industries. We would like to congratulate all of this year's winners; your dedication to superior service has resonated with the people of the GTA and its surrounding areas.




Fresenius Lead Dialysis Machine Market Fueled by Popularity of Home-Hemodialysis Treatment

Wed, 22 Feb 2017 14:00:00 EST

The market for hemodialysis machines is comprised of in-center machines and home hemodialysis machines; the market will exceed a value of $360 million by 2023




URAC Releases Standards for Patient Centered Medical Home Certification

Wed, 22 Feb 2017 11:00:00 EST

Announcement provides proprietary information to accelerate healthcare transformation




Konica Minolta Expands MSK Ultrasound Product Portfolio with Intuitive Portable Technology

Wed, 22 Feb 2017 10:11:49 EST

WAYNE, NJ--(Marketwired - February 22, 2017) - Konica Minolta Healthcare today announced the launch of its J5 Ultrasound System, a portable system with touch-screen intuitive navigation that produces high quality real-time images of the musculoskeletal (MSK) system. The new technology delivers the workflow benefits and diagnostic accuracy required to make critical point-of-care decisions during MSK evaluations.




eWellness to Present at the 2017 Wall Street Conference in Boca Raton on March 1, 2017

Wed, 22 Feb 2017 08:50:00 EST

CULVER CITY, CA--(Marketwired - Feb 22, 2017) - eWellness Healthcare Corporation, (OTCQB: EWLL) is the first telehealth company for physical therapy to offer insurance reimbursable remotely monitored physical therapy (PT) treatments. The Company will be presenting at the Wall Street Conference in Boca Raton Florida at 10:00am March 1, 2017. www.wallstconference.com




Global Small Caps Initiates Coverage on Nutra Pharma

Wed, 22 Feb 2017 08:30:00 EST

CORAL SPRINGS, FL--(Marketwired - Feb 22, 2017) - Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company developing drugs for the treatment of Multiple Sclerosis and HIV that also markets Nyloxin® and Pet Pain-AwayT in the over-the-counter (OTC) pain management market, announced today that Global Small Caps has initiated coverage of the Company including operations and overall shareholder value.




Lice Clinics of America Opens New Treatment Center in Miami

Wed, 22 Feb 2017 08:00:00 EST

Clinic provides guaranteed, one-and-done lice treatments using FDA-cleared medical device




Zenosense, Inc.: MIDS Quantitative Testing Commences

Wed, 22 Feb 2017 08:00:00 EST

VALENCIA, SPAIN--(Marketwired - Feb 22, 2017) - Zenosense, Inc. (OTCQB: ZENO) ("Zenosense", the "Company"), a healthcare technology company primarily focused on the development and commercialization of MIDS CardiacT, a Point of Care ("POC") handheld device for the early detection of certain cardiac event biomarkers to significantly accelerate the triage, diagnosis, treatment and disposition of patients reporting chest pain and with suspected acute myocardial infarction (heart attack), is pleased to announce that MIDS Medical Limited ("MML"), our joint venture based at Sci-Tech, Daresbury, has completed construction of two bench readers designed to test two methods of magnetic nanoparticle detection.




30% of Drug Companies Compensate HCPs Differently for International vs. Domestic Air Travel

Wed, 22 Feb 2017 07:48:00 EST

Pharma Companies Establish FMV Travel Policies for Healthcare Providers




Jacksonville Plastic Surgeons Answer Frequently Asked Questions About Labiaplasty and Recovery

Wed, 22 Feb 2017 07:01:00 EST

JACKSONVILLE, FL--(Marketwired - Feb 22, 2017) - Labiaplasty, also referred to as labia reduction surgery, is becoming a more popular procedure with each passing year. The treatment is designed to eliminate excess labial tissue, a common concern among many women that can cause extreme discomfort, as well as self-consciousness about their appearance. Drs. Ankit Desai, Joseph Parks, and Michael Fallucco with Florida Plastic Surgery Group say that labiaplasty is an advanced procedure that can improve both form and function in the treatment area with results that can greatly enhance one's livelihood.




Southwest Cannabis Conference & Expo Returns to Texas for Largest Event Yet

Wed, 22 Feb 2017 06:00:00 EST

DALLAS, TX--(Marketwired - Feb 22, 2017) - The Southwest Cannabis Conference & Expo (http://SWCCExpo.com) is returning to Texas for its second annual event. After setting new records at the last event in Phoenix -- where more than 150 exhibitors showcased their goods to over 6,800 attendees -- the SWCC Expo is looking to set new records in 2017.




5 Remarkable New Heart Health Innovations Made Possible by Plastics

Tue, 21 Feb 2017 13:40:05 EST

TORONTO, ON--(Marketwired - February 21, 2017) - Did you know that February is Heart Health Month? Given that we rely on a healthy heart regardless of the month, it's fortunate that innovations in heart care advance year round, year after year.




Dr. Ellen Turner Adds Vaginal Rejuvenation to Her Dermatology Services

Tue, 21 Feb 2017 13:30:00 EST

Modern technology has made nonsurgical vaginal rejuvenation an increasingly fast and safe treatment, leading Dr. Ellen Turner to add FemTouch(TM) to her Dallas dermatology practice




Therapia, the on-demand physiotherapy platform, launches to provide Canadians with physiotherapy in their homes

Tue, 21 Feb 2017 13:26:20 EST

The online platform allows patients to book appointments in their homes and workplaces with a therapist of their choosing




SADA Systems and Children's Hospital Los Angeles Medical Group Honored as Recipients of the 2017 Microsoft Health Innovation Awards

Tue, 21 Feb 2017 10:06:45 EST

The cloud services and technology consulting firm teamed up with the largest pediatric multispecialty medical group in the United States to help fight infant blindness in Armenia




Taglich Brothers Initiates Coverage on Aytu Bioscience, Inc.

Tue, 21 Feb 2017 10:04:43 EST

NEW YORK, NY--(Marketwired - February 21, 2017) - Taglich Brothers, Inc. announces it initiated coverage of AYTU Bioscience, Inc.




Las Vegas Plastic Surgeons Reveal Benefits of Clear + Brilliant Laser Therapy

Tue, 21 Feb 2017 10:01:00 EST

Dr. W. Tracy Hankins and Dr. Samuel M. Sohn discuss how Clear + Brilliant laser skin rejuvenation can enhance skin tone and texture, reduce common signs of aging, and create healthier-looking skin




EchoPixel Announces True 3D Print Support, Combining Virtual Reality and 3D Model Printing to Revolutionize Surgical Planning

Tue, 21 Feb 2017 10:00:00 EST

Suite of software tools built on EchoPixel's breakthrough Interactive Virtual Reality technology aim to provide fast, accurate, 3D models for a wide range of medical procedures




EchoPixel Announces CE Mark Certification for True 3D Viewer

Tue, 21 Feb 2017 10:00:00 EST

Virtual reality medical imaging company takes distribution overseas to expand in research and clinical applications across medical fields




Advantis Corp. Begins Distribution of Ground Breaking New Cannabis Products for Pain Relief

Tue, 21 Feb 2017 09:37:30 EST

NEWPORT BEACH, CA--(Marketwired - Feb 21, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) begins distribution of topical cannabis roll-on and Tinctures to treat pain conditions.




Emerald Health Accelerates Expansion with $13 Million Capital Raise -- CFN Media

Tue, 21 Feb 2017 09:15:00 EST

SEATTLE, WA--(Marketwired - Feb 21, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, today announced the publication of an article discussing Emerald Health Therapeutics Inc.'s (TSX VENTURE: EMH) recent financing and the company's plans for expansion of its facilities.




Arch Therapeutics, Inc. $6.1 Million Registered Direct Offering

Tue, 21 Feb 2017 09:08:29 EST

FRAMINGHAM, MA--(Marketwired - Feb 21, 2017) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a developer of innovative materials as hemostatic and wound care devices, today announced the pricing of a registered direct offering of 10,166,664 units, each unit consisting of a share of the Company's common stock, and 0.55 of a Series F Warrant ("Series F Warrant") to purchase one share of our common stock for the combined purchase price of $0.60 per unit. The Series F Warrants have an exercise price of $0.75 per share and are exercisable for a period of five years.




Avadim Technologies Inc.'s Newest Board Member, Humberto C. Antunes, Earns Lifetime Achievement Award

Tue, 21 Feb 2017 09:00:00 EST

Recognized for his Decades of Contributions Toward the Advancement of Dermatology and Aesthetics




FMV Budget is a Top Criterion Among Surveyed Companies When Evaluating IIT Proposals

Tue, 21 Feb 2017 08:36:00 EST

RESEARCH TRIANGLE PARK, NC--(Marketwired - February 21, 2017) - Nearly one-third of surveyed pharmaceutical companies look to fair-market value (FMV) budget as one their most important criteria for evaluating investigator initiated trial (IIT) proposals, according to a study by business intelligence firm Cutting Edge Information.




Medovex Corporation Provides Corporate Update

Tue, 21 Feb 2017 08:30:00 EST

Recent Completion of Final CE Mark Audit and Financing with Insider Participation Positions Company for 2017




Easton Pharmaceuticals / BMV Medica Announces Successful Product Sales Launch Conference Of Product Gynofit and Additional Distribution of Product AL-Sense (AmnioSense) With Multi-National Pharmaceutical Company Gedeon Richter

Tue, 21 Feb 2017 08:00:00 EST

TORONTO, ON--(Marketwired - Feb 21, 2017) - Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) and partner, BMV Medica SA, announce successful product launch of "Gynofit" and further announce final stage agreement with multi-national Gedeon Richter for the distribution of Easton / BMV's AL-Sense (AmnioSense) product.




MediXall Group, Inc. Announces Strategic Agreement with Renaissance Health System of Florida, Inc.

Tue, 21 Feb 2017 07:30:00 EST

FT. LAUDERDALE, FL--(Marketwired - Feb 21, 2017) - MediXall Group Inc. (OTCQB: MDXL) is a technology and innovation-driven organization structured to bring effective change to the U.S. healthcare industry.




TeraRecon Demonstrates Deep Learning Workflow at HIMSS17

Tue, 21 Feb 2017 07:00:00 EST

Prototype WIA Cloud engines learn from physician-driven workflow and improve automation in real-time




As 'Envelope in the Mail' Approach to Billing Falls Short, Healthcare Organizations May Find Transparency at Point of Service is Best Option

Tue, 21 Feb 2017 06:00:00 EST

CHICAGO, IL--(Marketwired - February 21, 2017) - Two in three healthcare executives recently stated in a survey that they need to focus their revenue cycle management on patient estimation/point-of-service collections and patient collections in the back office. Yet, only five percent of respondents indicated that price transparency was an area of focus. The results come from a TransUnion Healthcare (NYSE: TRU) survey of 106 healthcare executives, but do not reflect the reality that more patients are seeking transparency.